Original Research
Accepted on 15 Sep 2025
Cost-Effectiveness of HLX01 (Hanlikang®) vs. Rituximab Combined with CHOP in Treatment-Naive Diffuse Large B-Cell Lymphoma: A Partitioned Survival Model Analysis
in Drugs Outcomes Research and Policies
Original Research
Accepted on 15 Sep 2025
in Drugs Outcomes Research and Policies
Case Report
Accepted on 15 Sep 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 15 Sep 2025
in Intensive Care Medicine and Anesthesiology
Original Research
Accepted on 15 Sep 2025
in Mood Disorders
Original Research
Accepted on 15 Sep 2025
in Nutritional Epidemiology
Brief Research Report
Accepted on 15 Sep 2025
in Genetics and Epidemiology
Original Research
Accepted on 15 Sep 2025
in Cost and Resource Allocation
Original Research
Accepted on 15 Sep 2025
in Aging Psychiatry
Original Research
Accepted on 15 Sep 2025
in Marine Biology
Original Research
Accepted on 15 Sep 2025
in Translational Medicine
Original Research
Accepted on 15 Sep 2025
in Physical Education and Pedagogy
Original Research
Accepted on 15 Sep 2025
in Cardiovascular Imaging
Original Research
Accepted on 15 Sep 2025
in IoT Communication and Networking Protocols
Case Report
Accepted on 15 Sep 2025
in General Pediatrics and Pediatric Emergency Care
Systematic Review
Accepted on 15 Sep 2025
in Bee Protection and Health
Review
Accepted on 15 Sep 2025
in Nutrition and Metabolism